Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1
Clinical trial NCT00106158 · COMPLETED
Trial details
- NCT number
- NCT00106158
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.